the Effect of Light Therapy on Consequences in Dialysis Patients
Not Applicable
Completed
- Conditions
- Condition 1: Renal Failure. Condition 2: Pruritus. Condition 3: Inflammation. Condition 4: Pain.Chronic kidney disease, stage 5N18.5
- Registration Number
- IRCT20230925059505N1
- Lead Sponsor
- Bagheiat-allah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
All hemodialysis patients who have been treated with hemodialysis for 6 months
Exclusion Criteria
Having mental illnesses
Infectious skin diseases
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie light therapy's effects on renal failure and pruritus in dialysis patients?
How does light therapy compare to standard-of-care treatments for inflammation and pain in stage 5 chronic kidney disease?
Are there specific biomarkers that predict response to light therapy in N18.5 dialysis patients with pruritus?
What adverse events are associated with light therapy in renal failure patients and how are they managed?
What combination approaches or competitor drugs show promise for managing pruritus and inflammation in dialysis populations?